EuPA Open Proteomics (Dec 2015)

Proteomic profiling of hyperplasia/atypia and adenoma-induced by NNK in mouse lung identified multiple proteins as potential biomarkers for early detection

  • Arunangshu Das,
  • James D. Bortner, Jr.,
  • Cesar Aliaga,
  • Timothy Cooper,
  • Anne Stanley,
  • Bruce A. Stanley,
  • Chandra P. Belani,
  • Karam El-Bayoumy

Journal volume & issue
Vol. 9
pp. 23 – 33

Abstract

Read online

We used a proteomics approach (iTRAQ) to identify differentially expressed lung proteins during early stages of the tobacco carcinogen, NNK-induced lung tumorigenesis (hyperplasia/atypia, 4–10 weeks and adenoma, 25 week) prior to the detection of adenocarcinoma in A/J mice. We identified 790 proteins at week 4 and 710 proteins at weeks 10 and 25 with >95% confidence and a Local False Discovery Rate estimation less than 5%. We have demonstrated that NNK altered multiple protein (e.g., Carbonyl Reductase, Annexin A5/6, Selenbp1, Hmgb1 and Hsp90b1) expressions in early lesions which can be used as potential biomarkers for early detection of lung cancer. Keywords: Early biomarkers, Lung tumorigenesis, NNK, p-XSC, Proteomics